Eikon Therapeutics, Inc.
EIKN
$8.86
-$0.12-1.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 132.69% | 52.64% | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | -- | 69.99% | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | 0.00% | |||
| Total Current Assets | -- | 53.11% | |||
|
|
|||||
| Total Current Assets | -- | 53.11% | |||
| Net Property, Plant & Equipment | -- | -9.75% | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -- | 183.34% | |||
| Total Assets | -- | 21.07% | |||
|
|
|||||
| Total Accounts Payable | -- | -96.13% | |||
| Total Accrued Expenses | -- | 51.44% | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -- | 7.75% | |||
| Total Finance Division Other Current Liabilities | -- | -66.09% | |||
| Total Other Current Liabilities | -- | -66.09% | |||
| Total Current Liabilities | -- | -2.55% | |||
|
|
|||||
| Total Current Liabilities | -- | -2.55% | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -- | 28.03% | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | 86.99% | |||
| Total Liabilities | -- | 22.49% | |||
|
|
|||||
| Common Stock & APIC | -- | 25.64% | |||
| Retained Earnings | -- | -52.17% | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | 196.28% | -53.70% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | 43.71% | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | 43.71% | |||
|
|
|||||
| Total Common Equity | 196.28% | -53.70% | |||
| Total Preferred Equity | -- | 43.71% | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 133.05% | 19.53% | |||
|
|
|||||